Neuropeptide Y5 receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices

Journal of Neurophysiology

Volumn 83, Issue 2, 2000, Pages 723-734

  Ho, Melisa W Y ^a,c   Beck Sickinger, Annette G ^b,d   Colmers, William F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ETH ZURICH   (Switzerland)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPILEPTIC DISCHARGE; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SUBICULUM; SYNAPSE;

EID: 0033968095     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2000.83.2.723     Document Type: Article

References (35)

1. BARABAN, S. C., HOLLOPETER, G., ERICKSON, J. C., SCHWARTZKROIN, P. A., AND PALMITER, R. D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17: 8927-8936, 1997.
2. BARD, J. A., WALKER, M. W., BRANCHEK, T. A., AND WEINSHANK, R. L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270: 26762-26765, 1995.
3. 2 receptors with distinguished conformations. Eur. J. Biochem. 225: 947-958, 1994.
4. BINDOKAS, V. P., LEE, C. C., COLMERS, W. F., AND MILLER, R. J. Changes in mitochondrial function resulting from synaptic activity in the rat hippocampal slice. J. Neurosci. 18: 4570-4587, 1998.
5. o. Brain Res. 590: 128-135, 1992.
6. CLARK, S. AND WILSON, W. A. Brain slice model of epilepsy: neuronal networks and actions of antiepileptic drugs. In: Drugs for Control of Epilepsy: Actions in Neuronal Networks Involved in Seizure Disorders, edited by C. L. Faingold and G. H. Fromm. Boca Raton, FL: CRC, 1992, p. 89-121.
7. 5 receptors cannot suppress epileptiform activity in rat hippocampal slice. Soc. Neurosci. Abstr. 24: 1261, 1998.
8. COLMERS, W. F. AND BLEAKMAN, D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17: 373-379, 1994.
9. COLMERS, W. F., LUKOWIAK, K. D., AND PITTMAN, Q. J. Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J. Physiol. (Lond.) 383: 285-299, 1987.
10. DOODS, H. N., WIENEN, W., ENTZEROTH, M., RUDOLF, K., EBERLEIN, W., ENGEL, W., AND WIELAND, H. A. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther. 275: 136-142, 1995.
11. DUMONT, Y., FOURNIER, A., AND QUIRION, R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18: 5565-5574, 1998.
12. GERALD, C., WALKER, M. W., CRISCIONE, L., GUSTAFSON, E. L., BATZL-HARTMANN, C., SMITH, K. E., VAYSSE, P., DURKIN, M. M., LAZ, T. M., LINEMEYER, D. L., SCHAFFHAUSER, A. O., WHITEBREAD, S., HOFBAUER, K. G., TABER, R. I., BRANCHEK, T. A., AND WEINSHANK, R. L. A receptor suntype involved in neuropeptide-Y-induced food intake. Nature 382: 168-171, 1996.
13. GREENE, J.R.T. AND TOTTERDELL, S. Morphology and distribution of electrophysiologically defined classes of pyramidal and nonpyramidal neurons in rat ventral subiculum in vitro. J. Comp. Neurol. 380: 395-408, 1997.
14. GUSTAFSON, E. L., SMITH, K. E., DURKIN, M. M., WALKER, M. W., GERALD, C., WEINSHANK, R., AND BRANCHER, T. A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Res. Mol. Brain Res. 46: 223-235, 1997.
15. INGENHOVEN, N. AND BECK-SICKINGER, A. G. Fluorescence labelled analogues of neuropeptide Y for the characterisation of cells expressing NPY receptor subtypes. J. Recept. Signal Transduct. Res. 17: 407-418, 1997.
16. JACQUES, D., CADIEUX, A., DUMONT, Y., AND QUIRION, R. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on pruported Y1, Y2, and Y3 receptors. Eur. J. Pharmacol. 278: R3-R5, 1995.
17. KLAPSTEIN, G. J. AND COLMERS, W. F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3: 103-111, 1993.
18. KLAPSTEIN, G. J. AND COLMERS, W. F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78: 1651-1661, 1997.
19. LARSEN, P. J., SHEIKH, S. P., JAKOBSEN, C. R., SCHWARTZ, T. W., AND MIKKELSEN, J. D. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 5: 1622-1637, 1993.
20. MCNAMARA, J. O. Cellular and molecular basis of epilepsy. J. Neurosci. 14: 3413-3425, 1994.
21. MCQUISTON, A. R. AND COLMERS, W. F. Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study. Neurosci. Lett. 138: 261-264, 1992.
22. MCQUISTON, A. R. AND COLMERS, W. F. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol. 76: 3159-3168, 1996.
23. MCQUISTON, A. R., PETROZZINO, J. J., CONNOR, J. A., AND COLMERS, W. F. Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16: 1422-1429, 1996.
24. MICHEL, M. C., BECK-SICKINGER, A. G., COX, H. M., DOODS, H. N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T., WESTFALL, T., XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50: 143-150, 1998.
25. 2+ entry. J. Neurosci. 17: 8169-8177, 1997.
26. RIST, B., ENZEROTH, M., AND BECK-SICKINGER, A. G. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the hCGRP1 receptor. J. Med. Chem. 41: 117-123, 1998.
27. RIST, B., WIELAND, H. A., WILLIM, K. D., AND BECK-SICKINGER, A. G. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J. Pept. Sci. 1: 341-348, 1995.
28. RIST, B., ZERBE, O., INGENHOVEN, N., SCAPOZZA, L., PEERS, C., VAUGHAN, P.F.T., MC DONALD, R. L., WIELAND, H., AND BECK-SICKINGER, A. G. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. FEBS Lett. 394: 169-173, 1996.
29. RUDOLF, K., EBERLEIN, W., ENGEL, W., WIELAND, H. A., WILLIM, K. D., ENTZEROTH, M., WIENEN, W., BECK-SICKINGER, A. G., AND DOODS, H. N. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur. J. Pharamcol. 271: R11-R13, 1994.
30. SMIALOWSKA, M., BIJAK, M., SOPALA, M., AND TOKARSKI, K. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides 30: 7-12, 1996.
31. STASHEFF, S. F., BRAGDON, A. C., AND WILSON, W. A. Induction of epilepti-form activity in hippocampal slices by trains of electrical stimuli. Brain Res. 344: 296-302, 1985.
32. VEZZANI, A., SPERK, G., AND COLMERS, W. F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22: 25-30, 1999.
33. 125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Brain Res. 778: 242-250, 1997.
34. WOLDBYE, D. P., LARSEN, P. J., MIKKELSEN, J. D., KLEMP, K., MADSEN, T. M., AND BOLWIG, T. G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med. 3: 761-764, 1997.
35. WONG, R. K. AND TRAUB, R. D. Synchronized burst discharge in disinhibited hippocampal slice. I. Initiation in CA2-CA3 region. J. Neurophysiol. 49: 442-458, 1983.